Lopinavir (ABT-378): Precision Tools for HIV and Antiviral R
2026-06-29
Lopinavir (ABT-378) stands out for its unrivaled HIV protease inhibition, proven efficacy in serum-rich assays, and demonstrated cross-viral potential against emerging threats like MERS-CoV. Discover how researchers leverage this compound from APExBIO for robust, mutation-resistant workflows and troubleshooting in both classic and cutting-edge antiviral studies.
Histone H4K12 Lactylation Drives TNBC Progression via SLFN5
2026-06-29
This study uncovers a novel epigenetic mechanism in triple-negative breast cancer (TNBC), linking histone H4K12 lactylation to malignancy progression through the downregulation of SLFN5. By employing metabolic inhibitors such as sodium oxamate, the research demonstrates how targeting lactate-driven histone modifications can modulate tumor cell fate, suggesting new avenues for cancer metabolism research.
Jiedu Xiaozheng Yin Modulates Macrophage Phenotype via TLR4
2026-06-28
Liu et al. demonstrate that Jiedu Xiaozheng Yin (JXY) suppresses colitis-associated colorectal cancer (CAC) progression by promoting M1 macrophage polarization through the TLR4 pathway. This mechanistic insight expands the repertoire of immunomodulatory strategies for CAC, suggesting the TLR4 signaling axis as a promising therapeutic target.
IL-36/IL-36R Axis and NETosis in Psoriasis: Mechanistic Insi
2026-06-27
The referenced study elucidates how TLR ligands and purinergic signaling synergize to drive neutrophil extracellular trap (NET) formation, with IL-36/IL-36R signaling amplifying psoriatic skin inflammation. These findings highlight new avenues for targeting IL-36 and NETosis in the treatment of psoriasis.
Capsaicin (E)-Capsaicin: Novel Insights on TRPV1 and Itch Ci
2026-06-26
Explore the unique mechanisms of Capsaicin (E)-Capsaicin in TRPV1 ion channel activation, focusing on its emerging role in chronic dermatitis and sensory neuron modulation. This article delivers in-depth analysis and practical guidance for advanced pain and itch research.
Prestained Protein Marker (Triple Color, EDTA Free, 10-250 k
2026-06-26
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides clearly visible molecular weight standards for SDS-PAGE and Western blotting, allowing for accurate monitoring of protein separation and transfer. This marker is best suited for workflows requiring compatibility with Phosbind SDS-PAGE or fluorescent membrane imaging, and should not be used in workflows where EDTA is required or where its visible color bands may interfere with detection.
SB 202190: Precision p38 MAP Kinase Inhibitor for Cancer Mod
2026-06-25
SB 202190 empowers bench researchers with selective, potent inhibition of p38α/β MAPKs, enabling precise dissection of inflammation and tumor-immunity pathways. This article translates the latest colorectal cancer organoid-Treg co-culture findings into actionable workflows, protocol refinements, and troubleshooting insights for disease modeling.
Carrier-Free Triterpene Prodrugs for Targeted OSCC Chemother
2026-06-25
This study presents a carrier-free, self-assembled prodrug system using glycyrrhetinic acid and ginsenoside Rh2 for targeted oral squamous cell carcinoma (OSCC) chemotherapy. By leveraging a ROS-responsive linker and dual triterpene synergy, the approach enhances tumor selectivity and drug release efficiency, offering a promising direction for low-toxicity natural product-based chemotherapeutics.
Haloprogin: Mechanistic Insight and Strategy for Translation
2026-06-24
Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) is redefining translational research in antifungal and antimicrobial therapy. This article delivers a thought-leadership perspective, blending mechanistic insights, experimental best practices, and translational strategy—anchored in both foundational and contemporary evidence. We clarify Haloprogin’s unique value for researchers targeting dermatophytosis, Candida albicans, and Gram-positive bacterial infections, and provide actionable guidance for protocol optimization. By situating Haloprogin within an evolving competitive and regulatory landscape, we chart a path for its incorporation into next-generation antimicrobial workflows.
THZ1: Covalent CDK7 Inhibitor Workflows for Cancer Biology
2026-06-23
THZ1, a potent covalent CDK7 inhibitor, redefines transcription regulation studies in cancer research with its unique mechanism and benchmark antiproliferative activity. Discover actionable protocols, troubleshooting strategies, and insights from recent epigenetic studies to maximize assay fidelity and translational relevance.
CHK1 Inhibition and Hormone Receptor Status in Breast Cancer
2026-06-23
This study systematically investigates how the therapeutic effects of checkpoint kinase 1 (CHK1) inhibition in breast cancer depend on the tumor's estrogen and progesterone receptor (ER/PR) status. The findings clarify that CHK1 inhibition enhances chemotherapy sensitivity in ER−/PR−/HER2− cancers but acts as a single-agent antitumor strategy in ER+/PR+/HER2− cancers, informing more precise application of CHK1-targeted therapy.
Crystal Violet Staining Solution: Precision in Fungal Pathog
2026-06-22
Explore how Crystal Violet Staining Solution advances nuclear staining dye protocols for high-impact fungal pathogen research and cell-based assays. This article provides new insights into assay design and resistance profiling, revealing unique workflow considerations for modern laboratories.
WZ4003: Illuminating NUAK1/2 Inhibition in Cell Migration an
2026-06-22
Explore how WZ4003, a potent NUAK1/2 inhibitor, transforms cell migration, invasion, and tau phosphorylation research. This article provides a rigorous, mechanistic analysis and clarifies its unique value for translational cancer and neurodegenerative disease models.
Vitamin C in Organoid-Based Cancer and Antiviral Research
2026-06-21
Vitamin C (ascorbic acid) is redefining preclinical workflows as a dual-action anticancer and antiviral agent, uniquely effective in organoid and in vivo model systems. This article delivers protocol-driven guidance, troubleshooting strategies, and practical integration tips to maximize the reproducibility and impact of high-purity Vitamin C from APExBIO.
Lenalidomide (CC-5013): Deep Mechanistic Insights for Immuno
2026-06-20
Explore the multifaceted mechanisms of lenalidomide in immune modulation and angiogenesis inhibition, with a focus on practical assay design and translational research. This article provides advanced technical insights and a unique perspective on integrating epigenetic and immunological strategies in multiple myeloma studies.
466 records 14/32 page Previous Next First page 上5页 1112131415 下5页 Last page